ACCENDRA HEALTH INC/VA/ 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities Accendra Health, Inc.’s common stock trades on the New York Stock Exchange under the symbol ACH (formerly OMI). As of January 31, 2026, there were 1,772 common shareholders of record. Because many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, the common shareholders of record do not reflect the total number of stockholders. 5-Year Total Shareholder Return The following performance graph compares the performance of our common stock to the Russell 2000 Index and the Russell 3000 Medical Equipment and Services Sector Index, an index that includes more than 100 companies in the medical equipment and services industry. This graph assumes that the value of the investment in the common stock and each index was $100 on December 31, 2020, and that all dividends were reinvested. ​ 33 Table of Contents ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Base Period ​ ​ ​ Years Ended Company Name / Index ​ 12/2020 ​ 12/2021 ​ ​ ​ 12/2022 ​ ​ ​ 12/2023 ​ ​ ​ 12/2024 ​ ​ ​ 12/2025 Accendra Health, Inc. ​ $ 100.00 ​ $ 160.85 ​ $ 72.22 ​ $ 71.26 ​ $ 48.33 ​ $ 10.35 Russell 2000 Index ​ 100.00 ​ 114.78 ​ ​ 91.30 ​ ​ 106.71 ​ ​ 119.00 ​ ​ 134.23 Russell 3000 Medical Equipment and Services Sector ​ 100.00 ​ 120.76 ​ 93.91 ​ 98.59 ​ 104.83 ​ 110.56 ​ On February 26, 2025, our Board of Directors authorized a share repurchase program of up to $100 million and expires in February 2027. Under the program, we may repurchase shares of common stock on a discretionary basis from time to time through open market repurchases, privately negotiated transactions and 10b5-1 trading plans. ​ The following table summarizes share repurchase activity for the year ended December 31, 2025: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ (in thousands, except per share data) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Period ​ Total Number of Shares Purchased ​ ​ Average Price Paid Per Share ​ Total Number of Shares Purchased as Part of Publicly Announced Program (1) ​ ​ Approximate Dollar Value of Shares That May Yet be Purchased Under the Program (2) February 26-February 28, 2025 ​ — ​ $ — ​ — ​ $ 100,000 March 1-March 31, 2025 ​ 173 ​ $ 8.66 ​ 173 ​ $ 98,500 April 1-April 30, 2025 ​ 653 ​ $ 7.87 ​ 653 ​ $ 93,360 May 1-May 31, 2025 ​ — ​ $ — ​ — ​ $ 93,360 June 1-June 30, 2025 ​ — ​ $ — ​ — ​ $ 93,360 July 1-July 31, 2025 ​ — ​ $ — ​ — ​ $ 93,360 August 1-August 31, 2025 ​ — ​ $ — ​ — ​ $ 93,360 September 1-September 30, 2025 ​ — ​ $ — ​ — ​ $ 93,360 October 1-October 31, 2025 ​ — ​ $ — ​ — ​ $ 93,360 November 1-November 30, 2025 ​ 1,129 ​ $ 3.10 ​ 1,129 ​ $ 89,860 December 1-December 31, 2025 ​ — ​ $ — ​ — ​ $ 89,860 Total (3) ​ 1,955 ​ ​ ​ ​ 1,955 ​ ​ ​ ​ ​ (1) On February 26, 2025, our Board of Directors authorized a share repurchase program of up to $100 million. The program expires in February 2027. Under the program, we may repurchase shares of common stock on a discretionary basis from time to time through open market repurchases, privately negotiated transactions and 10b5-1 trading plans. (2) During the period from February 26, 2025 (the date the share repurchase program was authorized) through December 31, 2025, we repurchased shares in open-market transactions and retired approximately 2.0 million shares of our common stock for an aggregate of $10 million, or a weighted average price per share of $5.19. (3) Represents the period from February 26, 2025 (the date the share repurchase program was authorized) through December 31, 2025. ​ ​ Item 6. [Reserved]